文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19患者接受体外膜肺氧合支持时的气管切开实践与结局:体外生命支持组织登记数据分析

Tracheostomy Practices and Outcomes in Patients With COVID-19 Supported by Extracorporeal Membrane Oxygenation: An Analysis of the Extracorporeal Life Support Organization Registry.
PubMed 文献 · Crit Care Med · 2022-05-16
一句话结论COVID-19 ECMO患者32%在ECMO期间行气管切开、51%住院期间行气管切开,实施率与COVID前病毒性肺炎相似但更晚(中位10.0天 vs 6.7天),气管切开与更多活动及出血并发症相关,总体死亡率相似。

该回顾性队列研究基于体外生命支持组织登记数据,纳入7047例因COVID-19相关急性呼吸衰竭接受ECMO支持的患者,并与2019年COVID前病毒性肺炎患者比较气管切开实践、并发症与结局。结果显示32%的患者在ECMO期间记录有气管切开操作,51%在住院期间某个时点行气管切开;COVID前病毒性肺炎患者气管切开频率相似,但实施时间提前3天(中位6.7天[IQR 3.0-12.0天] vs 10.0天[IQR 5.0-16.5天],p<0.001)。COVID前病毒性肺炎患者更多被活动,但在两个队列中,ECMO期间接受气管切开均与活动增加相关;接受气管切开的患者出血并发症更多,COVID-19接受气管切开者中9%报告手术部位出血。总体死亡率在是否接受气管切开的患者间相似。

要点

  • 7047例COVID-19相关急性呼吸衰竭接受ECMO支持的患者中,32%在ECMO期间记录有气管切开操作,51%在住院期间某个时点行气管切开。
  • COVID前病毒性肺炎患者气管切开频率与COVID-19相似,但实施时间提前3天(中位6.7天[IQR 3.0-12.0天] vs 10.0天[IQR 5.0-16.5天],p<0.001)。
  • 在两个队列中,ECMO期间接受气管切开均与活动增加相关。
  • 接受气管切开的患者出血并发症更多,COVID-19接受气管切开者中9%报告手术部位出血。
  • 总体死亡率在是否接受气管切开的患者间相似。

适用人群与场景

  • 16岁及以上因COVID-19(2020年及2021年至2021年10月)接受静脉-静脉ECMO呼吸支持的患者。
  • 16岁及以上因COVID前病毒性肺炎(2019年)接受静脉-静脉ECMO呼吸支持的患者。
  • 数据来自向体外生命支持组织登记库贡献数据的ECMO中心。

研究设计与关键结果

  • 研究类型为回顾性队列研究,数据来自体外生命支持组织登记库,纳入7047例因COVID-19相关急性呼吸衰竭接受ECMO支持的患者。
  • 32%的患者在ECMO期间记录有气管切开操作,51%在住院期间某个时点行气管切开。
  • COVID前病毒性肺炎患者气管切开频率与COVID-19相似,但气管切开实施时间提前3天(中位6.7天[IQR 3.0-12.0天] vs 10.0天[IQR 5.0-16.5天];p<0.001)。
  • COVID前病毒性肺炎患者更多被活动,但在两个队列中,ECMO期间接受气管切开均与活动增加相关。
  • 接受气管切开的患者出血并发症更多,COVID-19接受气管切开者中9%报告手术部位出血。
  • 总体死亡率在是否接受气管切开的患者间相似。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在COVID-19患者接受ECMO支持期间,气管切开实施率与COVID前病毒性肺炎相似,但实施时间更晚(中位10.0天 vs 6.7天)。
  • ECMO期间接受气管切开与活动增加相关,但接受气管切开的患者出血并发症更多,COVID-19接受气管切开者中9%报告手术部位出血。
  • 是否接受气管切开与总体死亡率相似。

指南或共识出处

  • 体外生命支持组织登记库数据;研究发表于Critical Care Medicine。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The use of extracorporeal membrane oxygenation (ECMO) in patients with COVID-19 has been supported by major healthcare organizations, yet the role of specific management strategies during ECMO requires further study. We sought to characterize tracheostomy practices, complications, and outcomes in ECMO-supported patients with acute respiratory failure related to COVID-19.

DESIGN: Retrospective cohort study.

SETTING: ECMO centers contributing to the Extracorporeal Life Support Organization Registry.

PATIENTS: Patients 16 years or older receiving venovenous ECMO for respiratory support for: 1) COVID-19 in 2020 and 2021 (through October 2021) and 2) pre-COVID-19 viral pneumonia in 2019.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We identified 7,047 patients who received ECMO support for acute respiratory failure related to COVID-19. A total of 32% of patients were recorded as having a tracheostomy procedure during ECMO, and 51% had a tracheostomy at some point during hospitalization. The frequency of tracheostomy was similar in pre-COVID-19 viral pneumonia, but tracheostomies were performed 3 days earlier compared with patients with COVID-19 (median 6.7 d [interquartile range [IQR], 3.0-12.0 d] vs 10.0 d [IQR, 5.0-16.5 d]; p < 0.001). More patients were mobilized with pre-COVID-19 viral pneumonia, but receipt of a tracheostomy during ECMO was associated with increased mobilization in both cohorts. More bleeding complications occurred in patients who received a tracheostomy, with 9% of patients with COVID-19 who received a tracheostomy reported as having surgical site bleeding.

CONCLUSIONS: Tracheostomies are performed in COVID-19 patients receiving ECMO at rates similar to practices in pre-COVID-19 viral pneumonia, although later during the course of ECMO. Receipt of a tracheostomy was associated with increased patient mobilization. Overall mortality was similar between those who did and did not receive a tracheostomy.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kohne JG, MacLaren G, Cagino L, et al. Tracheostomy Practices and Outcomes in Patients With COVID-19 Supported by Extracorporeal Membrane Oxygenation: An Analysis of the Extracorporeal Life Support Organization Registry. Crit Care Med. 2022. PMID: 35607973. doi:10.1097/CCM.0000000000005579

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。